Stockscreener 앱 받기
25.53
0.87%
0.22
시간 외 거래:
25.53
Vera Therapeutics Inc 주식(VERA)의 최신 뉴스
Vera Therapeutics (VERA) Receives New Buy Rating from HC Wainwri - GuruFocus
(VERA) On The My Stocks Page - news.stocktradersdaily.com
Invesco Ltd. Raises Stock Position in Vera Therapeutics, Inc. (NASDAQ:VERA) - Defense World
A History of Outperforming Analyst Forecasts and Beating the Odds: Vera Therapeutics Inc (VERA) - Sete News
Vera Therapeutics Inc (VERA) Stock: Uncovering a 52-Week Range and Trading Volume - investchronicle.com
Insider’s View: Deciphering Vera Therapeutics Inc (VERA)’s Financial Health Through Ratios - DWinneX
Vera Therapeutics Inc (VERA)’s stock performance: a year in review - uspostnews.com
Vera Therapeutics (VERA) Expected to Announce Earnings on Thursday - Defense World
Vera Therapeutics, Inc. (NASDAQ:VERA) Receives Average Recommendation of “Buy” from Analysts - Defense World
Vera Therapeutics Inc (VERA) may enjoy gains as insiders got busy in the recent days - knoxdaily.com
Vera Therapeutics, Inc. (NASDAQ:VERA) Shares Acquired by Wells Fargo & Company MN - Defense World
A stock that deserves closer examination: Vera Therapeutics Inc (VERA) - uspostnews.com
Traders Purchase Large Volume of Call Options on Vera Therapeutics (NASDAQ:VERA) - Defense World
Vera Therapeutics Inc (VERA): What Are The Positives? - Marketing Sentinel
When (VERA) Moves Investors should Listen - news.stocktradersdaily.com
Vera Therapeutics Inc (NASDAQ: VERA) Received An -47.05% Loss In 6 Months – Here’s What To Expect - Marketing Sentinel
Alliancebernstein L.P. Boosts Holdings in Vera Therapeutics, Inc. (NASDAQ:VERA) - Defense World
Vera Therapeutics (VERA) Stock Sees After-Market Boost - Stocks Telegraph
After-Market Momentum Builds For ASP Isotopes (ASPI) Amid Secondary Listing News - Stocks Telegraph
Wellington Management Group LLP Trims Position in Vera Therapeutics, Inc. (NASDAQ:VERA) - Defense World
Vera Therapeutics, Inc. (NASDAQ:VERA) Shares Bought by JPMorgan Chase & Co. - Defense World
Polycythemia Vera Market to Show Remarkable Growth Trends from - openPR.com
Polycythemia Vera Therapeutics Market Set to Witness - openPR.com
Vera Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire
Kidney Disease-Focused Vera Therapeutics Concludes Enrollment In Pivotal Study, Targets 2026 Commercial Launch - Yahoo Finance
Vanguard Group Inc. Acquires 369,387 Shares of Vera Therapeutics, Inc. (NASDAQ:VERA) - Defense World
Vera Therapeutics, Inc. (NASDAQ:VERA) Shares Purchased by Corebridge Financial Inc. - Defense World
Vera Therapeutics, Inc. (NASDAQ:VERA) Receives Consensus Rating of “Buy” from Analysts - Defense World
KLP Kapitalforvaltning AS Makes New Investment in Vera Therapeutics, Inc. (NASDAQ:VERA) - Defense World
Vera Therapeutics completes enrollment for IgAN drug trial By Investing.com - Investing.com South Africa
Vera Therapeutics stock hits 52-week low at $21.44 By Investing.com - Investing.com South Africa
Vera Therapeutics stock hits 52-week low at $21.44 - Investing.com India
Vera Therapeutics completes enrollment for IgAN drug trial - Investing.com Australia
Vera Therapeutics completes enrollment in ORIGIN Phase 3 trial for atacicept - TipRanks
Vera Therapeutics Completes Full Enrollment in Pivotal ORIGIN Phase 3 Trial for Atacicept in IgAN - GlobeNewswire
Is Vera Therapeutics Inc (VERA) a threat to investors? - uspostnews.com
Vera Therapeutics Inc [VERA] stock was sold by Fordyce Marshall at the price of US$0.3 million - knoxdaily.com
Teacher Retirement System of Texas Acquires 3,942 Shares of Vera Therapeutics, Inc. (NASDAQ:VERA) - Defense World
Vera Therapeutics (NASDAQ:VERA) Reaches New 1-Year LowWhat's Next? - MarketBeat
69,724 Shares in Vera Therapeutics, Inc. (NASDAQ:VERA) Bought by Raymond James Financial Inc. - Defense World
Vera Therapeutics stock hits 52-week low at $25.97 By Investing.com - Investing.com South Africa
Vera Therapeutics stock hits 52-week low at $25.97 - Investing.com
Vera Therapeutics validates Fair Value bearish call with 42% decline By Investing.com - Investing.com UK
Swiss National Bank Purchases 15,700 Shares of Vera Therapeutics, Inc. (NASDAQ:VERA) - Defense World
Relative Strength Alert For Vera Therapeutics - Nasdaq
AlphaQuest LLC Takes Position in Vera Therapeutics, Inc. (NASDAQ:VERA) - Defense World
Vera Therapeutics, Inc. (NASDAQ:VERA) Shares Bought by Charles Schwab Investment Management Inc. - Defense World
Bank of New York Mellon Corp Acquires 7,895 Shares of Vera Therapeutics, Inc. (NASDAQ:VERA) - Defense World
Arizona State Retirement System Has $532,000 Position in Vera Therapeutics, Inc. (NASDAQ:VERA) - The AM Reporter
Is Vera Therapeutics (NASDAQ:VERA) Weighed On By Its Debt Load? - simplywall.st
Victory Capital Management Inc. Increases Stake in Vera Therapeutics, Inc. (NASDAQ:VERA) - Defense World
Vera Therapeutics, Inc. (NASDAQ:VERA) Given Average Recommendation of “Buy” by Analysts - Defense World
0.39%
3.66%
자본화:
|
볼륨(24시간):